• M J Uddin, A F Rahman, S Rahman, N M Momenuzzaman, A Rahman, A S Majumder, A M Mohibullah, A H Chowdhury, F N Malik, S A Ahsan, K Mohsin, M M Haq, A W Chowdhury, A M Sohrabuzzaman, M Rahman, B Chakraborty, R Rahman, S R Khan, K N Khan, A M Reza, K S Hussain, M Rashid, A K Choudhury, K K Karmakar, Z Ali, N Alam, Z Rahman, C S Kabir, D Banik, A Dutta, M Badiuzzaman, A W Islam, A H Sium, M D Hossain, N Ahmed, J Jahan, M S Islam, M M Arefin, F A Cader, S K Banerjee, H Hoque, M Shofiuddin, A Selim, P K Das, M Ahmed, B Dutto, S Alam, G K Paul, S K Paul, and M G Azam.
• Professor MG Azam, National Institute of Cardiovascular Diseases, Dhaka, Bangladesh; E-mail: mgazam71@yahoo.com.
• Mymensingh Med J. 2020 Apr 1; 29 (2): 488-494.

AbstractSince the first recorded case of SARS-CoV-2 in Bangladesh on 8th March 2020, COVID-19 has spread widely through different regions of the country, resulting in a necessity to re-evaluate the delivery of cardiovascular services, particularly procedures pertaining to interventional cardiology in resource-limited settings. Given its robust capacity for human-to-human transmission and potential of being a nosocomial source of infection, the disease has specific implications on healthcare systems and health care professionals faced with performing essential cardiac procedures in patients with a suspected or confirmed diagnosis of COVID-19. The limited resources in terms of cardiac catheterization laboratories that can be designated to treat only COVID positive patients are further compounded by the additional challenges of unavailability of widespread rapid testing on-site at tertiary cardiac hospitals in Bangladesh. This document prepared for our nation by the Bangladesh Society of Cardiovascular Interventions (BSCI) is intended to serve as a clinical practice guideline for cardiovascular health care professionals, with a focus on modifying standard practice of care during the COVID-19 pandemic, in order to ensure continuation of adequate and timely treatment of cardiovascular emergencies avoiding hospital-based transmission of SARS-COV-2 among healthcare professionals and the patients. This is an evolving document based on currently available global data and is tailored to healthcare systems in Bangladesh with particular focus on, but not limited to, invasive cardiology facilities (cardiac catheterization, electrophysiology & pacing labs). This guideline is limited to the provision of cardiovascular care, and it is expected that specific targeted pharmaco-therapeutics against SARS-CoV-2 be prescribed as stipulated by the National Guidelines on Clinical Management of Corona virus Disease 2019 (COVID-19) published by the Director General of Health Services, Ministry of Health and Family Welfare of Bangladesh.

16 keywords...

hide…